| AMCIL Limited (AMH) ORDINARY FULLY PAID |
Financials |
$329 |
Update - Notification of buy-back - AMH
|
31 Oct 2025 9:08AM |
$1.080 |
$1.035 |
fallen by
4.17%
|
|
| Acusensus Limited (ACE) ORDINARY FULLY PAID |
Information Technology |
$227 |
Speed Camera Contract Expansion in Queensland
|
31 Oct 2025 9:07AM |
$1.800 |
$1.600 |
fallen by
11.11%
|
|
ACE - Price-sensitive ASX Announcement
Full Release
Key Points
- Queensland Department of Transport and Main Roads expanded contract with Acusensus.
- Doubling of trailer-based speed enforcement units.
- Deployment from November 2025 through 2026.
- Contract value approximately $16.6 million.
- 92% decline in excessive speeding with current program.
- Each unit to operate for an initial five-year term.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| BSA Limited (BSA) ORDINARY FULLY PAID |
Industrials |
$9 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
31 Oct 2025 9:07AM |
$0.130 |
$0.115 |
fallen by
11.54%
|
|
BSA - Price-sensitive ASX Announcement
Full Release
Key Points
- Operating cash flow decline to ($4.7 million) due to redundancy-related cash outflows and volume drops.
- Net cash position at quarter's end was $19.0 million with no external borrowings.
- Revenue fell significantly to $17.5 million, a 77% decrease from the previous year.
- EBITDA for the period was $3.9 million, supported by transition payments.
- Staff restructuring in progress due to contract losses, with staff reduced from 150 to 50.
- Focus on refining operations and targeting growth opportunities in electric vehicle charging.
- The company is strategically managing unprofitable trading and assessing future directions.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Bubs Australia Limited (BUB) ORDINARY FULLY PAID |
Consumer Staple |
$130 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
31 Oct 2025 9:07AM |
$0.165 |
$0.145 |
fallen by
12.12%
|
|
BUB - Price-sensitive ASX Announcement
Full Release
Key Points
- Net revenue increased by 30% to $25.6 million.
- Gross profit margin rose to 46.4%.
- EBITDA achieved at $0.5 million.
- Cash reserves at $12.9 million, with $10 million in undrawn facilities.
- Negative operating cash flow due to inventory rebuild.
- Key personnel change: Jasmin Manner as President USA.
- Inventory challenges expected to be resolved by end of the current quarter.
- Anticipated FDA approval by end of 2025.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| PainChek Ltd (PCK) ORDINARY FULLY PAID |
Health Care |
$77 |
Investor Presentation
|
31 Oct 2025 9:07AM |
$0.046 |
$0.037 |
fallen by
19.57%
|
|
PCK - Price-sensitive ASX Announcement
Full Release
Key Points
- 115,000 contracted licenses with $5.6 million ARR.
- FDA De Novo clearance for PainChek app in the US.
- Expansion into infant care with the PainChek Infant app.
- Regulatory clearance in ANZ, EU, and pending in the US.
- Projected ARR target covers core operating costs in ANZ and UK.
- Strong pipeline of 47,000 new licenses.
- Focus on B2C and B2B markets for global market penetration.
- PainChek Ltd is targeting an operational break-even point in ANZ and UK.
- Consistent growth in clinical utility and world's largest pain database.
- Strategic partnerships and integrations with major healthcare systems.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Integral Diagnostics Limited (IDX) ORDINARY FULLY PAID |
Health Care |
$921 |
AGM - Chair's Address and Presentation
|
31 Oct 2025 9:07AM |
$2.480 |
$2.470 |
fallen by
0.40%
|
|
| Globe Metals & Mining Limited (GBE) ORDINARY FULLY PAID |
Materials |
$43 |
Appendix 4G and Corporate Governance Statement
|
31 Oct 2025 9:06AM |
$0.049 |
$0.051 |
risen by
4.08%
|
|
| Race Oncology Ltd (RAC) ORDINARY FULLY PAID |
Health Care |
$509 |
September 2025 Quarterly Activity Report and Appendix 4C
|
31 Oct 2025 9:06AM |
$3.500 |
$2.850 |
fallen by
18.57%
|
|
RAC - Price-sensitive ASX Announcement
Full Release
Key Points
- Discovery and filing of three patents for (E,E)-isoform of bisantrene.
- Phase 1 cardioprotection and anticancer trial of RC220 is ongoing.
- Regulatory approvals received in Hong Kong and South Korea.
- Cash and equivalents of $11.27 million as of September 2025.
- Significant focus on R&D and drug manufacturing.
- Additional $3.6 million funding raised through option conversions.
- (E,E)-bisantrene's mechanism involves G-quadruplex binding affecting cancer genes.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| PainChek Ltd (PCK) ORDINARY FULLY PAID |
Health Care |
$77 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
31 Oct 2025 9:06AM |
$0.046 |
$0.037 |
fallen by
19.57%
|
|
PCK - Price-sensitive ASX Announcement
Full Release
Key Points
- FDA De Novo clearance for PainChek Adult App in the US.
- Entry into the $175 million annual US long-term care market.
- 115,770 contracted licenses globally with an ARR of $5.6 million.
- Cash reserves of $6.3 million as of 30 September 2025.
- First US commercial agreement signed post-FDA clearance.
- PainChek Infant App targets $15 billion global market opportunity.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Pathkey.AI Ltd (PKY) ORDINARY FULLY PAID |
Information Technology |
$5 |
Quarterly Activities & Cashflow Report
|
31 Oct 2025 9:06AM |
$0.020 |
$0.015 |
fallen by
25%
|
|
PKY - Price-sensitive ASX Announcement
Full Release
Key Points
- Pathkey.AI's core platform, TrialKey, improves clinical trial success rates using AI.
- Cash position at the end of the quarter was $334,000.
- Net cash used in operating activities was $236,000.
- No cash receipts from customers during the quarter.
- Company plans to raise additional capital through equity securities.
- Pathkey is focusing on expanding market engagement and AI capabilities.
- Investments in AI-driven drug discovery and compound repurposing are ongoing.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Globe Metals & Mining Limited (GBE) ORDINARY FULLY PAID |
Materials |
$43 |
Annual Report to Shareholders
|
31 Oct 2025 9:05AM |
$0.049 |
$0.051 |
risen by
4.08%
|
|
| Nuchev Limited (NUC) ORDINARY FULLY PAID |
Consumer Staple |
$25 |
Corporate Governance Statement and Appendix 4G
|
31 Oct 2025 9:05AM |
$0.140 |
$0.160 |
risen by
14.29%
|
|
| Mach7 Technologies Limited (M7T) ORDINARY FULLY PAID |
Health Care |
$116 |
Q1 FY26 Results Presentation
|
31 Oct 2025 9:05AM |
$0.295 |
$0.495 |
risen by
67.80%
|
|
M7T - Price-sensitive ASX Announcement
Full Release
Key Points
- Mach7 Technologies reports Q1 FY26 financial highlights.
- CARR reached A$29.6 million, with a TCV of A$2.6 million.
- Closing cash reported at A$18.9 million with no debt.
- Focus on commercial transformation and operational efficiencies.
- Building intelligent imaging ecosystems and leveraging AI.
- Product innovation includes a new tele-imaging platform.
- Targeting growth in radiology, cardiology, and oncology markets.
- Emphasizing profitable growth through innovation and accountability.
- Share buy-back program paused pending strategic review.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Nuchev Limited (NUC) ORDINARY FULLY PAID |
Consumer Staple |
$25 |
Annual Report to Shareholders
|
31 Oct 2025 9:05AM |
$0.140 |
$0.160 |
risen by
14.29%
|
|
| Cuscal Limited (CCL) ORDINARY FULLY PAID |
Financials |
$743 |
Results of 2025 AGM
|
31 Oct 2025 9:04AM |
$4.150 |
$3.880 |
fallen by
6.51%
|
|
| Top End Energy Limited (TEE) ORDINARY FULLY PAID |
Energy |
$10 |
Quarterly Activities Report
|
31 Oct 2025 9:04AM |
$0.039 |
$0.037 |
fallen by
5.13%
|
|
TEE - Price-sensitive ASX Announcement
Full Release
Key Points
- Top End Energy Limited reported its activities for the quarter ending 30 September 2025.
- The company is advancing discussions for its Serpentine Natural Hydrogen Project in Kansas, USA.
- Top End Energy is focused on the Beetaloo Basin in Northern Territory, Australia, with strategic partner discussions underway.
- The company has undertaken substantive oil and gas exploration activities totaling approximately A$909,000.
- Top End Energy's cash balance was approximately A$2,554,000 as of 30 September 2025.
- The company established a Sponsored American Depositary Receipt on the OTCQB Venture Market.
- Top End Energy is leveraging U.S. Executive Orders to enhance its American portfolio.
- Top End Energy's Beetaloo Basin strategy aligns with President Trump's energy development directives.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Litchfield Minerals Limited (LMS) ORDINARY FULLY PAID |
Materials |
$31 |
200m Copper-Zinc Zone Demonstrates System Scale & Continuity
|
31 Oct 2025 9:03AM |
$0.675 |
$0.550 |
fallen by
18.52%
|
|
LMS - Price-sensitive ASX Announcement
Full Release
Key Points
- Intersection of 200m of continuous copper-zinc mineralization in hole OGRC014.
- High-grade mineralization includes 59m at ~2% chalcopyrite and ~3% sphalerite.
- Planned step-out drilling aims to extend high-grade continuity to ~600m.
- Use of IP and ground electromagnetics to refine drill targeting.
- 200m vertical continuity demonstrated between OGRC010 and OGRC014.
- Completion of an accelerated, systematic exploration program planned.
- Focus on large system potential beyond Oonagalabi main zone.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Antilles Gold Limited (AAU) ORDINARY FULLY PAID |
Materials |
$25 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
31 Oct 2025 9:03AM |
$0.009 |
$0.009 |
fallen by
0%
|
|
AAU - Price-sensitive ASX Announcement
Full Release
Key Points
- Net cash used in operating activities was $433,000.
- Investments in joint ventures totaled $399,000 for the quarter.
- Cash inflow from financing activities was $1,538,000.
- Binding MoU signed with Shandong Xinhai Mining for Nueva Sabana project.
- La Demajagua project planning for development in 2027-28.
- El Pilar and La Cristina exploration activities scheduled for 2026.
- Cash on hand at quarter end was A$1,829,000.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Orthocell Limited (OCC) ORDINARY FULLY PAID |
Health Care |
$275 |
Appendix 3Y - Michael McNulty
|
31 Oct 2025 9:03AM |
$1.135 |
$1.015 |
fallen by
10.57%
|
|
| Perennial Income Generator Fund (Managed Fund) (EIGA) |
Financials |
$27 |
EIGA Monthly Portfolio Disclosure
|
31 Oct 2025 9:03AM |
$3.760 |
$3.610 |
fallen by
3.99%
|
|
| Kuniko Limited (KNI) ORDINARY FULLY PAID |
Materials |
$9 |
Airborne Geophysics Underway at Commonwealth Project
|
31 Oct 2025 9:03AM |
$0.066 |
$0.070 |
risen by
6.06%
|
|
KNI - Price-sensitive ASX Announcement
Full Release
Key Points
- 328 line-kilometre MobileMT survey to map sulphide zones.
- Advanced electromagnetic imaging for 3D resistivity modelling.
- Geophysical program focuses on the Commonwealth-Silica Hill corridor.
- Community coordination with local landholders for low-impact data acquisition.
- Kuniko is focused on ethical sourcing and energy transition minerals.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| eInvest Better Future (Managed Fund) (IMPQ) |
Financials |
$39 |
IMPQ Monthly Portfolio Disclosure
|
31 Oct 2025 9:02AM |
$5.090 |
$4.770 |
fallen by
6.29%
|
|
| Jindalee Lithium Limited (JLL) ORDINARY FULLY PAID |
Materials |
$52 |
Quarterly Cashflow Report - September 2025
|
31 Oct 2025 9:01AM |
$0.545 |
$0.520 |
fallen by
4.59%
|
|
JLL - Price-sensitive ASX Announcement
Full Release
Key Points
- Negative cash flows from operating and investing activities.
- Net cash used in operating activities was AUD 1,024,000.
- Net cash used in investing activities was AUD 861,000.
- Cash and cash equivalents at end of period were AUD 2,099,000.
- Recent AUD 8 million raised through share placement.
- Company remains optimistic about meeting business objectives.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Polymetals Resources Ltd (POL) ORDINARY FULLY PAID |
Materials |
$283 |
Reinstatement to Quotation
|
31 Oct 2025 9:01AM |
$1.245 |
$1.055 |
fallen by
15.26%
|
|
POL - Price-sensitive ASX Announcement
Full Release
Key Points
- Polymetals Resources Ltd (ASX: POL) will have its trading suspension lifted.
- The reinstatement follows an announcement regarding a serious safety incident at the Endeavor Mine Site.
- ASX Compliance issued the announcement.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Jindalee Lithium Limited (JLL) ORDINARY FULLY PAID |
Materials |
$52 |
Quarterly Activities Report - September 2025
|
31 Oct 2025 9:01AM |
$0.545 |
$0.520 |
fallen by
4.59%
|
|
JLL - Price-sensitive ASX Announcement
Full Release
Key Points
- McDermitt Lithium Project designated as a FAST-41 Transparency Project.
- Non-binding LOI with SPAC to raise US$20-30M, listing on a US exchange.
- Value optimization program for magnesium by-products at McDermitt.
- US government support and strategic partnerships being pursued.
- Capital raising of $8 million and proposed equity line of credit of up to US$100M.
- Appointment of Tristan Garthe as Chief Financial Officer.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Call 1300 880 160
Start a chat
Schedule a call
